Abbott Laboratories

National Diagnostic Products

National Diagnostic Products is an Australian medtech company with over 30 years experience in designing and manufacturing blood glucose testing products.

LumiraDx

LumiraDx is a US-based diagnostic devices maker. IDTechEx spoke to LumiraDx at Medica 2022, where the company was showcasing its point-of-care testing platform.

Dexcom

Dexcom is a US-based biotech company, founded in 1999. The company is one of the market leaders in the continuous glucose monitoring (CGM) industry.

i-Sens

i-Sens is a Korean medical device company, founded in 2000 with headquarters in Seoul and subsidiaries across the world. The company is a major player in the Asian market for diabetes management devices.

Medical Devices for Remote Patient Monitoring of Chronic Conditions

Rising healthcare costs, an aging population and an increasing prevalence of chronic diseases are driving the uptake of remote patient monitoring (RPM) technologies. In their recent report, Remote Patient Monitoring 2023 - 2033: Technologies, Markets and Opportunities, IDTechEx forecasts the market for medical devices supporting RPM to reach US$45 billion by 2033.

Infinovo

Infinovo are a company developing CGM for diabetics. The company was only founded in 2016 and is based in Suzhou, China.

PKVitality

PKVitality are developing a non-invasive continuous glucose monitor using a microneedle-based skin patch and watch. Tess Skyrme, Technology Analyst at IDTechEx, interviewed Minh Le, General Manager of the company, to get an update from the company.

AbbVie

AbbVie is a biopharmaceutical company, spun out of Abbott Laboratories in 2013.

The Waning COVID-19 Pandemic's Lasting Effect on Point-Of-Care

COVID-19 testing at point of care peaked in Q1 2022. Is testing waning? What is COVID-19's lasting effect on point-of-care testing?

Diabetes Technology Market: Continuous Glucose Monitors Drives Growth

By the year 2032, IDTechEx predicts the test strip industry to make up only 6.7% of the overall diabetes management device market, down from a peak of 63.4% in 2010.